Fox, C. P., Ali, A. S., McIlroy, G., Thust, S., Martinez-Calle, N., Jackson, A. E., Hopkins, L. M., Thomas, C. M., Kassam, S., Wright, J., Chaganti, S., Smith, J., Chau, I., Culligan, D., Linton, K. M., Collins, G. P., Ferreri, A. J. M., Lewis, D., Davies, A. J., Johnson, R., …Cwynarski, K. (2021). A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial. Blood Advances, 5(20), 4073-4082. https://doi.org/10.1182/bloodadvances.2021004779